BioSpace News Archive

Protech Home Medical Corp. (the “ Company ” or “ Protech ”) (TSXV: PTQ) (OTCQX: PTQQF), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that it will be presenting at the 13th annual LD Micro Main Event investor conference December 14 th at 11am EDT/ 8am PDT. Greg Crawford, CEO of Protech will be presenting to a live, virtual audience. Webcasted Presentation Event:

- Increase reflects strength and sustainability of Abbott’s diversified business - Dividend increased for 49th consecutive year - Abbott remains an S&P 500 Dividend Aristocrat

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, today announced that it has entered into agreements with several institutional and accredited investors (the “Exercising Holders”) to exercise certain outstanding warrants to purchase an aggregate of up to 3,964,065 shares of common stock raising gross proce

Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the National Comprehensive Cancer Network® (NCCN) added three different XPOVIO® (selinexor) combination regimens to its Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for previou

MyMedBot, a digital health start-up helping organizations reopen safely during the Coronavirus pandemic, has announced that it will integrate a COVID-19 vaccination management system into its health screening solution

– Immune Stimulation Augmented by +1,300% at 6-months Post-NPS Treatment – – Statistically Significant Difference of Duration of Immune Response of NPS vs. Control: p=0.000094 - – Data to be Presented Today at the San Antonio Breast Cancer Symposium - NEW YORK, Dec. 11, 2020 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broa

Proteor, a France-based international group specialized in prosthetic and orthotic solutions, has successfully completed its acquisition of American brand Freedom Innovations and the major part of the product portfolio from Ottobock. With this acquisition, the Proteor group is fueling its strategy to be a glob

The National Association of Specialty Pharmacy applauds the 8-0 decision by the Supreme Court to restore Arkansas’ right to govern the amount that Pharmacy Benefit Managers reimburse pharmacies, in Rutledge v. the Pharmaceutical Care Management Association.

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 21st Annual New Ideas for the New Year Conference, which is being held virtually, on Wednesday, January 13, 2021. About Novanta Novanta is a leading global supplier of co

- IGM Biosciences, Inc. (NASDAQ: IGMS) (IGM) today announced the closing of its upsized underwritten public offering of 1,221,224 shares of its common stock, which includes the exercise of the underwriters’ option to purchase additional shares in full, and pre-funded warrants to purchase 1,334,332 shares of its common stock. The public offering price of common stock was $90.00 per share and the public offering price of each pre-funded warr